Elixinol Wellness Past Earnings Performance
Past criteria checks 0/6
Elixinol Wellness has been growing earnings at an average annual rate of 30.3%, while the Personal Products industry saw earnings growing at 3.6% annually. Revenues have been declining at an average rate of 38.6% per year.
Key information
30.3%
Earnings growth rate
41.0%
EPS growth rate
| Personal Products Industry Growth | 8.7% |
| Revenue growth rate | -38.6% |
| Return on equity | -116.2% |
| Net Margin | -90.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Elixinol Wellness makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 8 | -8 | 9 | 0 |
| 30 Sep 23 | 8 | -7 | 10 | 0 |
| 30 Jun 23 | 7 | -7 | 10 | 0 |
| 31 Mar 23 | 7 | -9 | 11 | 0 |
| 31 Dec 22 | 7 | -11 | 13 | 0 |
| 30 Sep 22 | 7 | -12 | 14 | 0 |
| 30 Jun 22 | 8 | -13 | 16 | 0 |
| 31 Mar 22 | 9 | -15 | 17 | 0 |
| 31 Dec 21 | 9 | -17 | 19 | 0 |
| 30 Sep 21 | 11 | -21 | 20 | 0 |
| 30 Jun 21 | 12 | -25 | 22 | 0 |
| 31 Mar 21 | 13 | -65 | 25 | 0 |
| 31 Dec 20 | 15 | -105 | 29 | 0 |
| 30 Jun 20 | 21 | -161 | 37 | 0 |
| 31 Mar 20 | 26 | -121 | 38 | 0 |
| 31 Dec 19 | 31 | -80 | 39 | 0 |
| 30 Jun 19 | 35 | -10 | 29 | 0 |
| 31 Mar 19 | 34 | -5 | 23 | 0 |
| 31 Dec 18 | 32 | 0 | 17 | 0 |
Quality Earnings: E8M is currently unprofitable.
Growing Profit Margin: E8M is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: E8M is unprofitable, but has reduced losses over the past 5 years at a rate of 30.3% per year.
Accelerating Growth: Unable to compare E8M's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: E8M is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (16.6%).
Return on Equity
High ROE: E8M has a negative Return on Equity (-116.17%), as it is currently unprofitable.